摘要
目的研究定喘汤治疗哮喘慢性持续期的疗效及不良反应。方法研究对象为整群选取2013年4月—2014年5月该院收治的哮喘慢性疾病患者136例,随机法分为干预组(n=68)和对照组(n=68),所有患者给予糖皮质激素长效β2受体激动剂吸入治疗,干预组在此基础上加用定喘汤煎服,持续治疗3个月,比较其疗效及不良反应。结果干预组总有效率89.7%与对照组72.1%比较差异有统计学意义(P<0.05);干预组不良反应率5.9%低于对照组16.2%,两组比较差异无统计学意义(P>0.05)。结论采用定喘汤治疗哮喘慢性持续期患者能显著缓解哮喘症状,提高其生活质量,疗效好,不良反应少。
Objective To research the curative effect and adverse reaction of asthma-reliving decoction in treatment of asthma chronic persistent period. Methods 136 cases of patients with asthma chronic disease admitted and treated in our hospital from April 2013 to May 2014 were selected as the research object and randomly divided into two groups with 68 cases in each, all patients were given inhaled treatment of glucocorticosteroid and long-β 2-agonist, the intervention group were given asthma-reliving decoction on this basis for 3 months, the curative effect and adverse reaction of the two groups were compared. Results The difference in the total effective rate between the intervention group and the control group had statistical significance,（89.7% vs 72.1%）,（P 0.05）,the difference in the adverse reaction rate between the intervention group and the control group had no statistical significance,（5.9% vs 16.2%）,（P0.05）. Conclusion Asthma-reliving decoction in treatment of patients with asthma chronic persistent period？can obviously relieve asthma symptoms and improve the quality of life with good curative effect and few adverse reactions.
出处
《中外医疗》
2016年第6期144-145,共2页
China & Foreign Medical Treatment
关键词
定喘汤
哮喘
持续期
不良反应
Asthma-reliving decoction
Asthma
Persistent period
Adverse reaction
